🇺🇸 FDA
Pipeline program

Tang-min Lin pill

2008L00307

Phase 3 small_molecule active

Quick answer

Tang-min Lin pill for Type 2 Diabetes is a Phase 3 program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Type 2 Diabetes
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials